(Reuters) - Eli Lilly on Friday was cleared of liability in the first trial involving claims that its antidepressant Cymbalta caused severe withdrawal symptoms, including suicidal thoughts and ...

The Food and Drug Administration (FDA) has announced a significant recall affecting over 550,000 bottles of duloxetine delayed-release capsules. This recall comes as a result of elevated levels of a ...

The largest review of ‘gold standard’ antidepressant withdrawal studies to date has identified the type and incidence of symptoms experienced by people discontinuing antidepressants, finding most ...

Thousands of bottles of a commonly prescribed antidepressant drug have been recalled by the FDA because they were found to contain a suspected cancer-causing chemical. Over 7,100 bottles of Duloxetine ...

A popular antidepressant taken by millions has been recalled after the pills were found to contain cancer chemical used in rocket fuel. The FDA announced that more than 233,003 bottles of duloxetine ...

Oct. 18, 2005 — The U.S. Food and Drug Administration (FDA) and Eli Lilly & Co. have warned healthcare professionals regarding the increased risk of hepatotoxicity associated with use of duloxetine ...